stop_circleTerminated/Withdrawn

Bacterial Infections

Bayer Identifier:
Trial_1310
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Ciprofloxacin versus Continued Parenteral Ceftazidime in Neutropenic Pediatric Cancer Patients who have Responded to Initial Parenteral Therapy

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

6 - 9 Years

Trial summary

Enrollment Goal
14
Trial Dates
June 1990 - August 1991
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteer
N/A

Trial design

Multi-Center, Prospective, Randomized, Third Party Blind Comparison of Oral Ciprofloxacin versus Continued Parenteral Ceftazidime in Neutropenic Pediatric Cancer Patients who have Responded to Initial Parenteral Therapy
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.